ATE254465T1 - Zubereitungen für die hormonale kontrazeption - Google Patents

Zubereitungen für die hormonale kontrazeption

Info

Publication number
ATE254465T1
ATE254465T1 AT01201945T AT01201945T ATE254465T1 AT E254465 T1 ATE254465 T1 AT E254465T1 AT 01201945 T AT01201945 T AT 01201945T AT 01201945 T AT01201945 T AT 01201945T AT E254465 T1 ATE254465 T1 AT E254465T1
Authority
AT
Austria
Prior art keywords
hormone units
estrogen
daily
phase
units
Prior art date
Application number
AT01201945T
Other languages
English (en)
Inventor
Beek Agatha Antonia Magdal Van
Bennink Herman Jan Ti Coelingh
Original Assignee
Pantarhei Bioscience Bv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pantarhei Bioscience Bv filed Critical Pantarhei Bioscience Bv
Application granted granted Critical
Publication of ATE254465T1 publication Critical patent/ATE254465T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gynecology & Obstetrics (AREA)
  • Endocrinology (AREA)
  • Reproductive Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Absorbent Articles And Supports Therefor (AREA)
  • Materials For Medical Uses (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Orthopedics, Nursing, And Contraception (AREA)
  • Transition And Organic Metals Composition Catalysts For Addition Polymerization (AREA)
  • Steroid Compounds (AREA)
AT01201945T 2001-05-23 2001-05-23 Zubereitungen für die hormonale kontrazeption ATE254465T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP01201945A EP1293210B1 (de) 2001-05-23 2001-05-23 Zubereitungen für die hormonale Kontrazeption

Publications (1)

Publication Number Publication Date
ATE254465T1 true ATE254465T1 (de) 2003-12-15

Family

ID=8180360

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01201945T ATE254465T1 (de) 2001-05-23 2001-05-23 Zubereitungen für die hormonale kontrazeption

Country Status (10)

Country Link
US (1) US20040242550A1 (de)
EP (1) EP1293210B1 (de)
AT (1) ATE254465T1 (de)
CA (1) CA2448280A1 (de)
DE (1) DE60101276T2 (de)
DK (1) DK1293210T3 (de)
ES (1) ES2208518T3 (de)
PT (1) PT1293210E (de)
TR (1) TR200400183T4 (de)
WO (1) WO2002094281A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK1556058T3 (da) 2002-10-23 2008-03-03 Pantarhei Bioscience Bv Farmaceutiske præparater omfattende östetrolderivater til anvendelse i cancerterapi
EP1462106A1 (de) * 2003-03-28 2004-09-29 Pantarhei Bioscience B.V. Pharmazeutishe Zusammensetzungen und Kits enthaltend 17-Betaestradiol und Progesteron zur Behandlung von Gynäcologischen Storungen
DK1462107T3 (da) * 2003-03-28 2008-11-03 Pantarhei Bioscience Bv Fremgangsmåde til kvindelig kontraception og kit til anvendelse i en sådan fremgangsmåde
DE102004026671A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Darreichungsform zur hormonalen Kontrazeption
DE102004026670A1 (de) 2004-05-28 2005-12-15 Grünenthal GmbH Hormonales Kontrazeptivum enthaltend eine Kombination aus Ethinylestradiol und Chlormadinonacetat
WO2006036055A2 (en) * 2004-09-27 2006-04-06 Pantarhei Bioscience B. V. Method of female contraception and kit for use in such method
DE102005056527A1 (de) * 2005-11-25 2007-07-12 Grünenthal GmbH Verwendung einer Kombination aus Ethinylestradiol und Chlormadinonacetat zur Herstellung eines Arzneimittels
DE102006003508A1 (de) * 2006-01-24 2007-07-26 Grünenthal GmbH Arzneimittel umfassend eine Hormonkombination
US20080021003A1 (en) * 2006-06-13 2008-01-24 Vladimir Hanes Extended step-down estrogen regimen
CA2988498C (en) 2015-06-18 2022-02-08 Mithra Pharmaceuticals S.A. Orodispersible dosage unit containing an estetrol component
RS62844B1 (sr) 2015-06-18 2022-02-28 Estetra Srl Orodisperzibilna dozna jedinica koja sadrži komponentu estetrola
JOP20200260A1 (ar) 2018-04-19 2019-10-19 Estetra Sprl مركبات واستخداماتها للتخفيف من الأعراض المصاحبة لانقطاع الطمث
TWI801561B (zh) 2018-04-19 2023-05-11 比利時商依思特拉私人有限責任公司 化合物及其用於緩解絕經相關症狀的用途
CN109820859A (zh) * 2019-04-09 2019-05-31 上海市计划生育科学研究所 醋酸诺美孕酮在制备预防或治疗呕吐或改善恶病质的药物中的应用
WO2023135506A1 (en) * 2022-01-13 2023-07-20 Arena Pharmaceuticals, Inc. Etrasimod for use in treating s1p1 receptor-associated disorders in combination with hormone treatment

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
US4921843A (en) * 1988-10-20 1990-05-01 Pasquale Samuel A Contraception system and method
JPS60174716A (ja) * 1984-02-21 1985-09-09 Yamanouchi Pharmaceut Co Ltd パツチ剤
US4752478A (en) * 1984-12-17 1988-06-21 Merck & Co., Inc. Transdermal system for timolol
DE4224534A1 (de) * 1992-07-24 1994-01-27 Marika Dr Med Ehrlich Ovulationshemmendes Mittel zur hormonalen Kontrazeption
DE4344405C2 (de) * 1993-12-24 1995-12-07 Marika Dr Med Ehrlich Ovulationshemmendes Mittel und Verfahren zur hormonalen Kontrazeption
DE4429374C1 (de) * 1994-08-12 1996-02-01 Jenapharm Gmbh Pharmazeutische Präparate zur Kontrazeption/Hormonsubstitution mit biogener Estrogenkomponente

Also Published As

Publication number Publication date
DE60101276T2 (de) 2004-04-22
EP1293210A1 (de) 2003-03-19
EP1293210B1 (de) 2003-11-19
CA2448280A1 (en) 2002-11-28
DE60101276D1 (de) 2003-12-24
PT1293210E (pt) 2004-04-30
WO2002094281A1 (en) 2002-11-28
US20040242550A1 (en) 2004-12-02
ES2208518T3 (es) 2004-06-16
TR200400183T4 (tr) 2004-02-23
DK1293210T3 (da) 2004-03-15

Similar Documents

Publication Publication Date Title
DE60101276D1 (de) Zubereitungen für die hormonale Kontrazeption
ATE241361T1 (de) Mittel zur hormonalen kontrazeption
DK0491438T3 (da) Svangerskabsforebyggende behandling
RS20060348A (en) Extended use combination comprising estrogens and progestins
WO2003039553B1 (en) Compositions for treatment of postmenopausal female sexual dysfunction
CY1464A (en) Multiphase combined preparation and its use for oral contraception
HUP0300335A2 (hu) 8béta-hidrokarbil-szubsztituált ösztratriének mint szelektív hatású ösztrogének, alkalmazásuk és ezeket tartalmazó gyógyszerkészítmények
IS4753A (is) Getnaðarvarnaraðferð og -samstæða fyrir kvenkyns spendýr, sem inniheldur samsetningu með gestageni og estrógeni
TR199802705T2 (xx) Progestojen-anti-progestojen k�r�
BG104451A (en) Antiestrogen and progestin-containing peroral contraceptives
PL356847A1 (en) Hormonal composition based on a progesterone and an oestrogen and use thereof
BR0206367A (pt) Uso de antigestágenos para inibir o amadurecimento endométrico acelerado durante o tratamento da infertilidade
Wood Hormonal contraception: current perspectives. Part I. An analysis of available agents
BR0010070A (pt) Uso de org 33245, kit contraceptivo, meio combinado para a dosagem de um progestogênio e um antiprogestogênio, e, métodos de contracepção, e de tratamento de sangramento uterino irregular ou de ruptura em uma fêmea utilizando uma preparação somente de progestogênio
Shah Use of progestational compounds in gynaecology and obstetrics
ANDREWS et al. EFFECTS OF PROGESTIN-INDUCED PSEUDOPREGNANCY ON ENDOMETRIOSIS: CLINICAL AND MICROSCOPIC STUDIES
NO974255L (no) Preparat for injeksjon én gang pr. måned og som er anvendbart som depot-befruktningshemmende middel og i hormon-erstatningsterapi for perimenopausale og premenopausale kvinner
UY26965A1 (es) Uso de antiprogestinas para la profilaxis y el tratamiento de enfermedades dependientes de hormonas
UA31211A (uk) Спосіб специфічної профілактики резус-конфлікту

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1293210

Country of ref document: EP

REN Ceased due to non-payment of the annual fee